Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 21, 2021

Primary Completion Date

July 1, 2024

Study Completion Date

July 1, 2024

Conditions

Pregnancy RelatedAnemia, Iron Deficiency

Interventions

DRUG

Ferumoxytol Injection [Feraheme]

510mg intravenous ferumoxytol

DRUG

Ferrous Sulfate

325mg oral ferrous sulfate

Trial Locations (1)

Stanford University School of Medicine/Lucile Packard Childrens Hospital, Stanford

All Listed Sponsors

collaborator

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

lead

Stanford University

OTHER

NCT04253626 - Comparison of Oral Ferrous Sulfate to Intravenous Ferumoxytol in Antepartum Iron Deficiency Anemia | Biotech Hunter | Biotech Hunter